Status | Study |
Withdrawn |
Study Name: Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma Condition: Childhood Malignant Fibrous Histiocytoma of Bone Sarcoma Date: 2006-06-07 Interventions: Drug: glutamine Procedure: chemoprotection |
Withdrawn |
Study Name: Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma Condition: Childhood Malignant Fibrous Histiocytoma of Bone Sarcoma Date: 2006-06-07 Interventions: Drug: doxorubicin hydrochloride Drug: ifos |
Completed |
Study Name: Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans Condition: Dermatofibrosarcoma Protuberans Date: 2005-10-20 Interventions: Drug: imatinib mesylate 400 mg orally twice a day for 10 - 14 days |
Completed |
Study Name: Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes Condition: Hypereosinophilic Syndrome Systemic Mastocytosis Chronic M Date: 2005-09-13 Interventions: Drug: imatinib mesylate Other Name: STI571 |
Completed |
Study Name: Clinical Outcome of Pediatric Dermatofibrosarcoma Protuberans Condition: Soft Tissue Neoplasms Date: 2005-09-12 |
Completed |
Study Name: Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases Condition: Life Threatening Diseases Date: 2005-09-09 Interventions: Drug: Imatinib mesylate |
Completed |
Study Name: Imatinib in Dermatofibrosarcoma Protuberans (DFSP) Condition: Dermatofibrosarcoma Date: 2005-07-20 Interventions: Drug: Imatinib (Glivec) |
Completed |
Study Name: Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans Condition: Adult Fibrosarcoma Dermatofibrosarcoma Protuberans Date: 2004-06-10 Interventions: Drug: imatinib mesylate Given |
Completed |
Study Name: Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma Condition: Sarcoma Date: 2004-06-10 Interventions: Drug: imatinib mesylate Procedure: convent |